These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4076839)

  • 21. Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments.
    Fareed J; Walenga JM; Williamson K; Emanuele RM; Kumar A; Hoppensteadt DA
    Semin Thromb Hemost; 1985 Jan; 11(1):56-74. PubMed ID: 3883500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are molecular weight and anti-Xa activity sufficient to predict the antithrombotic power of heparin fractions.
    Doutremepuich C; Bousquet F; Toulemonde F
    Thromb Res; 1986 Dec; 44(5):709-12. PubMed ID: 3810569
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits.
    Holmer E; Mattsson C; Nilsson S
    Thromb Res; 1982 Mar; 25(6):475-85. PubMed ID: 7112507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis.
    Bratt G; Törnebohm E; Granqvist S; Aberg W; Lockner D
    Thromb Haemost; 1985 Dec; 54(4):813-7. PubMed ID: 3911482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
    Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
    Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fraction.
    Ockelford PA; Carter CJ; Mitchell L; Hirsh J
    Thromb Res; 1982 Nov; 28(3):401-9. PubMed ID: 7179224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
    Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
    Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis.
    Hollenbach S; Sinha U; Lin PH; Needham K; Frey L; Hancock T; Wong A; Wolf D
    Thromb Haemost; 1994 Mar; 71(3):357-62. PubMed ID: 8029801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic profile of the antithrombotic and bleeding actions of sulfated lactobionic acid amides.
    Raake W; Klauser RJ; Meinetsberger E; Zeller P; Elling H
    Semin Thromb Hemost; 1991; 17 Suppl 1():129-35. PubMed ID: 2068566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.
    Malm K; Dahlbäck B; Arnljots B
    Plast Reconstr Surg; 2003 Apr; 111(5):1659-66. PubMed ID: 12655212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low molecular weight heparin in hemodialysis patients with a bleeding tendency.
    Leu JG; Chiang SS; Lin SM; Pai JK; Jiang WW
    Nephron; 2000 Dec; 86(4):499-501. PubMed ID: 11124600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-course of anti-Xa effects of calcium heparin and low-molecular-weight heparin given s.c.: insights for thrombosis prevention.
    Romeo G; Salanitri G; Catania G
    Drugs Exp Clin Res; 1988; 14(6):423-7. PubMed ID: 2850903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J
    J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved microsurgical anastomotic patency with low molecular weight heparin.
    Ritter EF; Cronan JC; Rudner AM; Serafin D; Klitzman B
    J Reconstr Microsurg; 1998 Jul; 14(5):331-6. PubMed ID: 9714039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of low molecular weight heparin on coagulation parameters and bleeding time in healthy volunteers.
    Warning A; Nies D; Wolf H; Welzel D
    Arzneimittelforschung; 1987 Jul; 37(7):847-9. PubMed ID: 2823841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New class of heparin derivatives with a potent antithrombotic effect and a very limited hemorrhagic activity.
    Doutremepuich C; Azougagh Oualane F; Doutremepuich F; Fareed J
    Thromb Res; 1996 Aug; 83(3):217-28. PubMed ID: 8840463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment.
    Bratt G; Törnebohm E; Lockner D; Bergström K
    Thromb Haemost; 1985 Apr; 53(2):208-11. PubMed ID: 4024029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.